PEMBROCABOSARC: Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas. Engagement of patient participation in genomics research by the Osteosarcoma and Leiomyosarcoma Count ...
A randomized, double-blind, active-control, multicenter phase 3 trial of casdatifan and cabozantinib versus placebo and cabozantinib in patients with advanced clear cell RCC. Treatment options remain ...
A phase II, randomized, double-blind study of the use of rucaparib vs placebo maintenance therapy in metastatic and recurrent endometrial cancer. This is an ASCO Meeting Abstract from the 2023 ASCO ...
This world's first clinical study on sweet proteins, reflects the clinical relevance of Amai Protein's sweelin®. The double-blind, randomized, crossover clinical study confirmed that sweelin® does not ...
Research in Sweden led by the University of Uppsala has looked into using mesenchymal stromal cells to halt the progress of newly diagnosed type 1 diabetes. In the paper, "Umbilical cord-derived ...
Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results